UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
or

Kura Oncology (KURA)

Kura Oncology (KURA)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
6.52 +0.14 (+2.19%) 04/02/25 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 6.47 -0.05 (-0.77%) 18:05 ET
Quote Overview for Wed, Apr 2nd, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
6.27
Day High
6.56
Open 6.31
Previous Close 6.38 6.38
Volume 1,231,200 1,231,200
Avg Vol 1,151,735 1,151,735
Stochastic %K 10.21% 10.21%
Weighted Alpha -67.27 -67.27
5-Day Change -0.62 (-8.68%) -0.62 (-8.68%)
52-Week Range 6.27 - 23.48 6.27 - 23.48
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 515,217
  • Shares Outstanding, K 80,755
  • Annual Sales, $ 53,880 K
  • Annual Income, $ -173,980 K
  • EBIT $ -247 M
  • EBITDA $ -259 M
  • 60-Month Beta 0.83
  • Price/Sales 9.89
  • Price/Cash Flow N/A
  • Price/Book 1.24

Options Overview Details

View History
  • Implied Volatility 86.93% ( -10.33%)
  • Historical Volatility 53.14%
  • IV Percentile 64%
  • IV Rank 42.92%
  • IV High 172.19% on 01/03/25
  • IV Low 22.80% on 09/11/24
  • Put/Call Vol Ratio 0.00
  • Today's Volume 27
  • Volume Avg (30-Day) 68
  • Put/Call OI Ratio 0.22
  • Today's Open Interest 5,541
  • Open Int (30-Day) 5,579

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 16 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate -0.56
  • Number of Estimates 7
  • High Estimate -0.04
  • Low Estimate -0.87
  • Prior Year -0.59
  • Growth Rate Est. (year over year) +5.08%

Price Performance

See More
Period Period Low Period High Performance
1-Month
6.27 +3.99%
on 04/02/25
Period Open: 7.71
8.04 -18.91%
on 03/21/25
-1.19 (-15.43%)
since 02/28/25
3-Month
6.27 +3.99%
on 04/02/25
Period Open: 8.68
9.16 -28.82%
on 02/05/25
-2.16 (-24.88%)
since 01/02/25
52-Week
6.27 +3.99%
on 04/02/25
Period Open: 20.52
23.48 -72.23%
on 07/16/24
-14.00 (-68.23%)
since 04/02/24

Most Recent Stories

More News
Kura Oncology to Participate in Stifel Targeted Oncology Forum

KURA : 6.52 (+2.19%)
Kura Oncology Announces Preclinical Data for KO-2806 Selected for Oral Presentation at the 2025 AACR Annual Meeting

KURA : 6.52 (+2.19%)
Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

KURA : 6.52 (+2.19%)
Kura Oncology: Q4 Earnings Snapshot

Kura Oncology: Q4 Earnings Snapshot

KURA : 6.52 (+2.19%)
Kura Oncology Reports Fourth Quarter and Full Year 2024 Financial Results

KURA : 6.52 (+2.19%)
Kura Oncology to Participate in Three Upcoming Investor Conferences

KURA : 6.52 (+2.19%)
Kura Oncology to Report Fourth Quarter and Full Year 2024 Financial Results

KURA : 6.52 (+2.19%)
Here’s Why Shuttle Pharma is the Most Undervalued Biotech Stock in Our Coverage Universe

KURA : 6.52 (+2.19%)
SHPH : 0.4190 (+2.77%)
LPTX : 0.3400 (+16.72%)
NXTC : 0.4000 (-8.47%)
ACET : 0.7240 (-1.50%)
Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

KURA : 6.52 (+2.19%)
Kura Oncology and Kyowa Kirin Announce Positive Ziftomenib Monotherapy Registrational Trial and Positive FDA Feedback for Upcoming Frontline Combination Trial Designs

KURA : 6.52 (+2.19%)

Business Summary

Kura Oncology, Inc. is a biopharmaceutical company. The company is involved in the discovery and development of therapeutics for the treatment of tumors and blood cancers. Its product pipeline includes small molecule drug candidates which are in different clinical trial consists of Tipifarnib-HRAS, Tipifarnib-PTCL,...

See More

Key Turning Points

3rd Resistance Point 6.92
2nd Resistance Point 6.74
1st Resistance Point 6.63
Last Price 6.52
1st Support Level 6.34
2nd Support Level 6.16
3rd Support Level 6.05

See More

52-Week High 23.48
Fibonacci 61.8% 16.91
Fibonacci 50% 14.88
Fibonacci 38.2% 12.84
Last Price 6.52
52-Week Low 6.27

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Trader's Cheat Sheet: Your Secret Weapon for Smarter Trades